1. Home
  2. CAPS vs HOOK Comparison

CAPS vs HOOK Comparison

Compare CAPS & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAPS
  • HOOK
  • Stock Information
  • Founded
  • CAPS 1987
  • HOOK 2011
  • Country
  • CAPS United States
  • HOOK United States
  • Employees
  • CAPS N/A
  • HOOK N/A
  • Industry
  • CAPS
  • HOOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAPS
  • HOOK Health Care
  • Exchange
  • CAPS NYSE
  • HOOK Nasdaq
  • Market Cap
  • CAPS 9.8M
  • HOOK 9.3M
  • IPO Year
  • CAPS N/A
  • HOOK 2019
  • Fundamental
  • Price
  • CAPS $1.67
  • HOOK $1.25
  • Analyst Decision
  • CAPS
  • HOOK Buy
  • Analyst Count
  • CAPS 0
  • HOOK 4
  • Target Price
  • CAPS N/A
  • HOOK $10.67
  • AVG Volume (30 Days)
  • CAPS 26.2K
  • HOOK 63.1K
  • Earning Date
  • CAPS 04-02-2025
  • HOOK 08-07-2025
  • Dividend Yield
  • CAPS N/A
  • HOOK N/A
  • EPS Growth
  • CAPS N/A
  • HOOK N/A
  • EPS
  • CAPS N/A
  • HOOK N/A
  • Revenue
  • CAPS $43,416,000.00
  • HOOK $9,351,000.00
  • Revenue This Year
  • CAPS $7.87
  • HOOK N/A
  • Revenue Next Year
  • CAPS N/A
  • HOOK N/A
  • P/E Ratio
  • CAPS N/A
  • HOOK N/A
  • Revenue Growth
  • CAPS N/A
  • HOOK N/A
  • 52 Week Low
  • CAPS $1.58
  • HOOK $0.72
  • 52 Week High
  • CAPS $16.18
  • HOOK $6.77
  • Technical
  • Relative Strength Index (RSI)
  • CAPS N/A
  • HOOK 38.94
  • Support Level
  • CAPS N/A
  • HOOK $1.23
  • Resistance Level
  • CAPS N/A
  • HOOK $1.30
  • Average True Range (ATR)
  • CAPS 0.00
  • HOOK 0.06
  • MACD
  • CAPS 0.00
  • HOOK -0.03
  • Stochastic Oscillator
  • CAPS 0.00
  • HOOK 5.97

About CAPS CAPSTONE HOLDING CORP

Capstone Holding Corp is a building products distribution network. The existing network is comprised of Instone, a distributor of thin veneer stone and related masonry products in the United States, serving both residential and commercial construction markets. The company's product offering includes manufactured and natural stone products, supported by a distribution network. The company's current products include stone veneer, landscape stone, and modular masonry fireplaces.

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.

Share on Social Networks: